We examine the key stories to watch in 2018: Sagan vs. Van Avermaet, Froome's Salbutamol scandal, and much more.
Since his first Tour de France win in 2013, Chris Froome has been the GC rider of reference in the Tour. Through 2017, the Brit won four yellow jerseys (2013, 2015, 2016, 2017), a polka-dot jersey (2015), and six stages along the way, plus he won a stage in the 2012 Tour. He also won the 2017 Vuelta, but that is now under investigation due to an adverse analytical finding in an anti-doping test after stage 18.
Born in Nairobi, Froome has been a central part of British team Sky since 2010, where he’s also hauled in a number of major wins, including three stages at the Vuelta, three yellow jerseys at Critérium du Dauphiné, and seven other titles at smaller stage races, such as Tour de Romandie and Critérium International. Froome also won silver in both the 2012 and 2016 Olympics time trial events.
At face value, Froome's Tour-Vuelta double earns him cyclist of the year award, but time will tell with his pending Salbutamol scandal.
There is evidence suggesting an athlete could return a positive test after having taken the legal dose of the drug
Asthma expert Dr. John Dickinson explains Salbutamol, exercise-induced asthma, and how Froome will try to prove his innocence.
Chris Froome's Vuelta anti-doping test has thrown the 2018 cycling season into limbo. Here's the latest from our experts.
Grand tour organizers are taking a "wait-and-see" approach to the Chris Froome imbroglio over his Vuelta anti-doping test results.
The Sky rider had higher-than-allowed amounts of Salbutamol in his system during the Vuelta a Espana.
Romain Bardet, third at the Tour in 2017, said Sunday that Chris Froome's adverse drugs test had damaged the credibility of cycling.
We talk to Andrew Hood to break down the key storylines behind Chris Froome's doping test from the Vuelta.
Merely a decade ago, cycling was nearly undone by a litany of doping controversies. Now, another scandal looks poised to rock the sport as